{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T16:50:20Z","timestamp":1772902220164,"version":"3.50.1"},"reference-count":187,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["LISBOA-01-0247-FEDER-047213"],"award-info":[{"award-number":["LISBOA-01-0247-FEDER-047213"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/04138\/2020"],"award-info":[{"award-number":["UIDB\/04138\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/04138\/2020"],"award-info":[{"award-number":["UIDP\/04138\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.lfs.2023.121838","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T17:48:27Z","timestamp":1686160107000},"page":"121838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential"],"prefix":"10.1016","volume":"329","author":[{"given":"Mariana Pinto","family":"Coelho","sequence":"first","affiliation":[]},{"given":"Patr\u00edcia","family":"Duarte","sequence":"additional","affiliation":[]},{"given":"Marta","family":"Calado","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio J.","family":"Almeida","sequence":"additional","affiliation":[]},{"given":"Catarina Pinto","family":"Reis","sequence":"additional","affiliation":[]},{"given":"M. Manuela","family":"Gaspar","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.lfs.2023.121838_bb0005","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.lfs.2005.09.011","article-title":"Chemical constituents of marijuana: the complex mixture of natural cannabinoids","volume":"78","author":"ElSohly","year":"2005","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.lfs.2023.121838_bb0010","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.2174\/0929867324666170810164636","article-title":"Cannabis phenolics and their bioactivities","volume":"25","author":"Pollastro","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.lfs.2023.121838_bb0015","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.foodchem.2018.04.078","article-title":"Nutraceutical potential of hemp (Cannabis sativa L.) seeds and sprouts","volume":"262","author":"Frassinetti","year":"2018","journal-title":"Food Chem."},{"issue":"9","key":"10.1016\/j.lfs.2023.121838_bb0020","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.3390\/molecules26092774","article-title":"Cannabinoids, phenolics, terpenes and alkaloids of cannabis","volume":"26","author":"Radwan","year":"2021","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"8","key":"10.1016\/j.lfs.2023.121838_bb0025","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure, and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.lfs.2023.121838_bb0030","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s00425-019-03138-x","article-title":"Cannabimimetic plants: are they new cannabinoidergic modulators?","volume":"249","author":"Kumar","year":"2019","journal-title":"Planta"},{"issue":"5","key":"10.1016\/j.lfs.2023.121838_bb0035","first-page":"605","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol. Pharmacol."},{"issue":"6284","key":"10.1016\/j.lfs.2023.121838_bb0040","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"issue":"5090","key":"10.1016\/j.lfs.2023.121838_bb0045","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.lfs.2023.121838_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23063344","article-title":"Cannabinoids: therapeutic use in clinical practice","volume":"23","author":"Pagano","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3\u20134","key":"10.1016\/j.lfs.2023.121838_bb0060","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000521683","article-title":"Therapeutic potential of cannabis, cannabidiol, and cannabinoid-based pharmaceuticals","volume":"107","author":"Legare","year":"2022","journal-title":"Pharmacology"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2023.121838_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2006.02.001","article-title":"Cannabinoids in medicine: a review of their therapeutic potential","volume":"105","author":"Ben Amar","year":"2006","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.lfs.2023.121838_bb0070","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.phrs.2017.05.005","article-title":"Cannabidiol in medical marijuana: research vistas and potential opportunities","volume":"121","author":"Rong","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2023.121838_bb0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2017.02.041","article-title":"Cannabidiol: state of the art and new challenges for therapeutic applications","volume":"175","author":"Pisanti","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.lfs.2023.121838_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7812\/TPP\/20.156","article-title":"The role of cannabidiol in neurological disorders","volume":"25","author":"Chayasirisobhon","year":"2021","journal-title":"Permanente J."},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0085","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev-neuro-062111-150420","article-title":"Multiple functions of endocannabinoid signaling in the brain","volume":"35","author":"Katona","year":"2012","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.lfs.2023.121838_bb0090","series-title":"Cannabinoids","first-page":"299","article-title":"Distribution of cannabinoid receptors in the central and peripheral nervous system","author":"Mackie","year":"2005"},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0095","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/alcalc\/agh110","article-title":"The endocannabinoid system: physiology and pharmacology","volume":"40","author":"Rodr\u00cdGuez de Fonseca","year":"2005","journal-title":"Alcohol Alcohol."},{"issue":"11","key":"10.1016\/j.lfs.2023.121838_bb0100","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.lfs.2023.121838_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2023.121838_bb0110","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0306-4522(97)00436-3","article-title":"Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system","volume":"83","author":"Tsou","year":"1998","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.lfs.2023.121838_bb0115","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","article-title":"Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain","volume":"77","author":"Glass","year":"1997","journal-title":"Neuroscience"},{"issue":"10","key":"10.1016\/j.lfs.2023.121838_bb0120","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/0166-2236(90)90124-S","article-title":"The cannabinoid receptor: biochemical, anatomical and behavioral characterization","volume":"13","author":"Howlett","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.lfs.2023.121838_bb0125","series-title":"Endocannabinoids","first-page":"59","article-title":"Distribution of the endocannabinoid system in the central nervous system","author":"Hu","year":"2015"},{"issue":"6441","key":"10.1016\/j.lfs.2023.121838_bb0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2023.121838_bb0135","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399409000957","article-title":"Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation","volume":"11","author":"Cabral","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"issue":"35","key":"10.1016\/j.lfs.2023.121838_bb0140","doi-asserted-by":"crossref","first-page":"11136","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","article-title":"Cannabinoid CB<sub>2<\/sub> receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer\u2019s disease brains","volume":"23","author":"Benito","year":"2003","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0145","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2377-6-12","article-title":"COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells\/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord","volume":"6","author":"Yiangou","year":"2006","journal-title":"BMC Neurol."},{"issue":"5746","key":"10.1016\/j.lfs.2023.121838_bb0150","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1126\/science.1115740","article-title":"Identification and functional characterization of brainstem cannabinoid CB2 receptors","volume":"310","author":"Van Sickle","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.lfs.2023.121838_bb0155","series-title":"The Human Endocannabinoid System","author":"MedRealeaf","year":"2023"},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0160","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121838_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030747","article-title":"The endocannabinoid system: a target for cancer treatment","volume":"21","author":"Laezza","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.lfs.2023.121838_bb0170","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.tips.2015.02.008","article-title":"Endocannabinoid signaling at the periphery: 50 years after THC","volume":"36","author":"Maccarrone","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2023.121838_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093067","article-title":"Cannabidiol and other non-psychoactive cannabinoids for prevention and treatment of gastrointestinal disorders: useful nutraceuticals?","volume":"21","author":"Mart\u00ednez","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.lfs.2023.121838_bb0180","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1111\/febs.12302","article-title":"What do we know about the transient receptor potential vanilloid 2 (TRPV2) ion channel?","volume":"280","author":"Per\u00e1lvarez-Mar\u00edn","year":"2013","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.lfs.2023.121838_bb0185","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1476-5381.2011.01601.x","article-title":"The thermo-TRP ion channel family: properties and therapeutic implications","volume":"165","author":"Vay","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.lfs.2023.121838_bb0190","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1021\/cn5000919","article-title":"TRP channel cannabinoid receptors in skin sensation, homeostasis, and inflammation","volume":"5","author":"Caterina","year":"2014","journal-title":"ACS Chem. Neurosci."},{"issue":"8","key":"10.1016\/j.lfs.2023.121838_bb0195","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.bbadis.2007.01.008","article-title":"TRP channels: targets for the relief of pain","volume":"1772","author":"Levine","year":"2007","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.lfs.2023.121838_bb0200","series-title":"Advances in Pharmacology","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/bs.apha.2017.04.001","article-title":"Chapter eight - actions and regulation of ionotropic cannabinoid receptors","author":"De Petrocellis","year":"2017"},{"issue":"24","key":"10.1016\/j.lfs.2023.121838_bb0205","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1523\/JNEUROSCI.0504-08.2008","article-title":"TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons","volume":"28","author":"Qin","year":"2008","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.lfs.2023.121838_bb0210","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"De Petrocellis","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2023.121838_bb0215","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1748-1716.2011.02338.x","article-title":"Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation","volume":"204","author":"De Petrocellis","year":"2012","journal-title":"Acta Physiol (Oxford)"},{"issue":"3","key":"10.1016\/j.lfs.2023.121838_bb0220","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1124\/jpet.107.134809","article-title":"Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin Type-1 and melastatin type-8","volume":"325","author":"De Petrocellis","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"11","key":"10.1016\/j.lfs.2023.121838_bb0225","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1038\/npp.2012.100","article-title":"Acute stress increases circulating anandamide and other N-acylethanolamines in healthy humans","volume":"37","author":"Dlugos","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.lfs.2023.121838_bb0230","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13229-018-0203-y","article-title":"Plasma anandamide concentrations are lower in children with autism spectrum disorder","volume":"9","author":"Karhson","year":"2018","journal-title":"Mol. Autism"},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0235","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/npp.2017.130","article-title":"Circulating endocannabinoids: from whence do they come and where are they going?","volume":"43","author":"Hillard","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0240","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13229-019-0256-6","article-title":"Lower circulating endocannabinoid levels in children with autism spectrum disorder","volume":"10","author":"Aran","year":"2019","journal-title":"Mol. Autism"},{"issue":"3","key":"10.1016\/j.lfs.2023.121838_bb0245","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.neurobiolaging.2012.06.005","article-title":"CB2 receptor and amyloid pathology in frontal cortex of Alzheimer\u2019s disease patients","volume":"34","author":"Solas","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"9","key":"10.1016\/j.lfs.2023.121838_bb0250","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrd.2018.115","article-title":"New approaches and challenges to targeting the endocannabinoid system","volume":"17","author":"Di Marzo","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2023.121838_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/agriculture11050384","article-title":"Extraction of cannabinoids from Cannabis sativa L. (hemp)\u2014review","volume":"11","author":"Valizadehderakhshan","year":"2021","journal-title":"Agriculture"},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0260","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s42238-021-00087-9","article-title":"Processing and extraction methods of medicinal cannabis: a narrative review","volume":"3","author":"Lazarjani","year":"2021","journal-title":"J. Cannabis Res."},{"key":"10.1016\/j.lfs.2023.121838_bb0265","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cofs.2019.03.009","article-title":"The evolving landscape of cannabis edibles","volume":"28","author":"Blake","year":"2019","journal-title":"Curr. Opin. Food Sci."},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0003-2670(98)00233-5","article-title":"Soxhlet extraction of solid materials: an outdated technique with a promising innovative future","volume":"369","author":"Luque de Castro","year":"1998","journal-title":"Anal. Chim. Acta"},{"issue":"3","key":"10.1016\/j.lfs.2023.121838_bb0275","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/can.2018.0067","article-title":"Extractions of medical cannabis cultivars and the role of decarboxylation in optimal receptor responses","volume":"4","author":"Lewis-Bakker","year":"2019","journal-title":"Cannabis Cannabinoid Res."},{"issue":"7","key":"10.1016\/j.lfs.2023.121838_bb0280","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1080\/87559129.2019.1600539","article-title":"Hemp (Cannabis sativa L.) extract: anti-microbial properties, methods of extraction, and potential oral delivery","volume":"35","author":"Fathordoobady","year":"2019","journal-title":"Food Rev. Int."},{"issue":"4","key":"10.1016\/j.lfs.2023.121838_bb0285","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jfoodeng.2013.01.014","article-title":"Techniques for extraction of bioactive compounds from plant materials: a review","volume":"117","author":"Azmir","year":"2013","journal-title":"J. Food Eng."},{"key":"10.1016\/j.lfs.2023.121838_bb0290","article-title":"Green Analytical Methodologies for Preparation of Extracts and Analysis of Bioactive Compounds","volume":"65","author":"Duarte","year":"2014"},{"key":"10.1016\/j.lfs.2023.121838_bb0295","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7868\/S0044450215080216","article-title":"Transformations of tetrahydrocannabinol, tetrahydrocannabinolic acid and cannabinol during their extraction from Cannabis sativa L","volume":"70","author":"Wianowska","year":"2015","journal-title":"\u0416\u0443\u0440\u043d\u0430\u043b \u0430\u043d\u0430\u043b\u0438\u0442\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u0445\u0438\u043c\u0438\u0438"},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0300","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.forsciint.2004.05.015","article-title":"Isolation of \u03949-THCA-A from hemp and analytical aspects concerning the determination of \u03949-THC in cannabis products","volume":"149","author":"Dussy","year":"2005","journal-title":"Forensic Sci. Int."},{"issue":"2","key":"10.1016\/j.lfs.2023.121838_bb0305","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/pca.2800030210","article-title":"A new chromatographic method for the isolation of (\u2212)-\u03949-(trans)-tetrahydrocannabinolic acid A","volume":"3","author":"Lehmann","year":"1992","journal-title":"Phytochem. Anal."},{"key":"10.1016\/j.lfs.2023.121838_bb0310","first-page":"1","article-title":"Cannabis oil: chemical evaluation of an upcoming cannabis- based medicine","volume":"1","author":"Romano","year":"2013","journal-title":"Cannabinoids"},{"key":"10.1016\/j.lfs.2023.121838_bb0315","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.supflu.2017.03.014","article-title":"Supercritical carbon dioxide extraction of cannabinoids from Cannabis sativa L","volume":"129","author":"Rovetto","year":"2017","journal-title":"J. Supercrit. Fluids"},{"issue":"6","key":"10.1016\/j.lfs.2023.121838_bb0320","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2131\/jts.40.797","article-title":"Understanding dabs: contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing","volume":"40","author":"Raber","year":"2015","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.lfs.2023.121838_bb0325","first-page":"1891","article-title":"Antibacterial activity of clove, cinnamon, and datura extracts against Erwinia carotovora subsp. atroseptica causative agent of black stem and soft rot on potato","volume":"6","author":"Adhab","year":"2012","journal-title":"J. Med. Plant Res."},{"key":"10.1016\/j.lfs.2023.121838_bb0330","first-page":"35","article-title":"Developing novel one-step processes for obtaining food-grade O\/W emulsions from pressurized fluid extracts: processes description, state of the art and perspectives","author":"Santos","year":"2015","journal-title":"Food Sci. Technol. (Campinas)"},{"key":"10.1016\/j.lfs.2023.121838_bb0335","first-page":"1","article-title":"Comprehensive comparison of industrial cannabinoid extraction techniques: evaluation of the most relevant patents and studies at pilot scale","author":"L\u00f3pez-Olmos","year":"2022","journal-title":"Front. Nat. Prod."},{"key":"10.1016\/j.lfs.2023.121838_bb0340","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fpls.2016.00019","article-title":"Cannabis sativa: the plant of the thousand and one molecules","volume":"7","author":"Andre","year":"2016","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.lfs.2023.121838_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179472","article-title":"The endocannabinoid system: a potential target for the treatment of various diseases","volume":"22","author":"Lowe","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.121838_bb0350","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jep.2018.09.004","article-title":"Cannabis sativa: a comprehensive ethnopharmacological review of a medicinal plant with a long history","volume":"227","author":"Bonini","year":"2018","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121838_bb0355","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.molmed.2019.11.002","article-title":"Missing pieces to the endocannabinoid puzzle","volume":"26","author":"Maccarrone","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.lfs.2023.121838_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104822","article-title":"Cannabis sativa: much more beyond \u0394(9)-tetrahydrocannabinol","volume":"157","author":"Alves","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.lfs.2023.121838_bb0365","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/sj.bjp.0707399","article-title":"Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences","volume":"152","author":"McPartland","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2023.121838_bb0370","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01487","article-title":"Targeting cannabinoid signaling in the immune system: \u201chigh\u201d-ly exciting questions, possibilities, and challenges","volume":"8","author":"Ol\u00e1h","year":"2017","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.lfs.2023.121838_bb0375","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.bmc.2015.01.059","article-title":"Cannabidiol (CBD) and its analogs: a review of their effects on inflammation","volume":"23","author":"Burstein","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"14","key":"10.1016\/j.lfs.2023.121838_bb0380","doi-asserted-by":"crossref","first-page":"8711","DOI":"10.1074\/jbc.M114.618447","article-title":"Fatty acid-binding proteins (FABPs) are intracellular carriers for \u03949-tetrahydrocannabinol (THC) and Cannabidiol (CBD)*","volume":"290","author":"Elmes","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.lfs.2023.121838_bb0385","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","article-title":"Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb","volume":"30","author":"Izzo","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0390","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","article-title":"The endocannabinoid system and the brain","volume":"64","author":"Mechoulam","year":"2013","journal-title":"Annu. Rev. Psychol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0395","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1476-5381.2009.00515.x","article-title":"Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist","volume":"159","author":"Cascio","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0400","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11481-009-9177-z","article-title":"Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels","volume":"5","author":"De Petrocellis","year":"2010","journal-title":"J. NeuroImmune Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0405","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/0970-1591.60440","article-title":"Functional role of cannabinoid receptors in urinary bladder","volume":"26","author":"Tyagi","year":"2010","journal-title":"Indian J. Urol."},{"issue":"9","key":"10.1016\/j.lfs.2023.121838_bb0410","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.bcp.2013.01.017","article-title":"Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease","volume":"85","author":"Borrelli","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121838_bb0415","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.neuint.2013.08.002","article-title":"The effect of cannabichromene on adult neural stem\/progenitor cells","volume":"63","author":"Shinjyo","year":"2013","journal-title":"Neurochem. Int."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2023.121838_bb0420","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.drugalcdep.2010.05.019","article-title":"Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by \u0394(9)-tetrahydrocannabinol","volume":"112","author":"DeLong","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.lfs.2023.121838_bb0425","series-title":"Handbook of Cannabis","year":"2014"},{"issue":"2","key":"10.1016\/j.lfs.2023.121838_bb0430","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0306-3623(83)90004-6","article-title":"Neurobehavioral actions of cannabichromene and interactions with delta 9-tetrahydrocannabinol","volume":"14","author":"Davis","year":"1983","journal-title":"Gen. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121838_bb0435","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1476-5381.2010.01063.x","article-title":"Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action","volume":"162","author":"Maione","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2023.121838_bb0440","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.214","article-title":"Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression","volume":"1","author":"Amada","year":"2013","journal-title":"PeerJ"},{"issue":"11","key":"10.1016\/j.lfs.2023.121838_bb0445","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1021\/cn5000524","article-title":"Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability","volume":"5","author":"Iannotti","year":"2014","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.lfs.2023.121838_bb0450","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1083\/jcb.200305129","article-title":"Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain","volume":"163","author":"Bisogno","year":"2003","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0455","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0014-2999(03)01295-0","article-title":"Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a \u201cCB3\u201d receptor","volume":"461","author":"Fride","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2023.121838_bb0460","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2217\/pmt-2020-0110","article-title":"Cannabis-based medicines and pain: a review of potential synergistic and entourage effects","volume":"11","author":"Anand","year":"2021","journal-title":"Pain Manag."},{"key":"10.1016\/j.lfs.2023.121838_bb0465","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.3389\/fpls.2018.01969","article-title":"The case for the entourage effect and conventional breeding of clinical cannabis: no \u201cstrain,\u201d no gain","volume":"9","author":"Russo","year":"2018","journal-title":"Front. Plant Sci."},{"issue":"2","key":"10.1016\/j.lfs.2023.121838_bb0470","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/1570159X17666190903103923","article-title":"The \u201centourage effect\u201d: terpenes coupled with cannabinoids for the treatment of mood disorders and anxiety disorders","volume":"18","author":"Ferber","year":"2020","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0475","doi-asserted-by":"crossref","first-page":"8232","DOI":"10.1038\/s41598-021-87740-8","article-title":"Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity","volume":"11","author":"LaVigne","year":"2021","journal-title":"Sci. Rep."},{"issue":"16","key":"10.1016\/j.lfs.2023.121838_bb0480","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s40265-018-0996-1","article-title":"Medical use of cannabinoids","volume":"78","author":"Fraguas-S\u00e1nchez","year":"2018","journal-title":"Drugs"},{"issue":"6773","key":"10.1016\/j.lfs.2023.121838_bb0485","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/35003583","article-title":"Cannabinoids control spasticity and tremor in a multiple sclerosis model","volume":"404","author":"Baker","year":"2000","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.lfs.2023.121838_bb0490","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1177\/1352458513485982","article-title":"Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors","volume":"19","author":"Pryce","year":"2013","journal-title":"Mult. Scler. J."},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0495","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/jpet.103.051920","article-title":"The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy","volume":"307","author":"Wallace","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"8","key":"10.1016\/j.lfs.2023.121838_bb0500","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1111\/j.1476-5381.2012.02207.x","article-title":"Cannabidivarin is anticonvulsant in mouse and rat","volume":"167","author":"Hill","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121838_bb0505","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/bph.12321","article-title":"Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism","volume":"170","author":"Hill","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2023.121838_bb0510","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.nbd.2004.03.002","article-title":"Effects on turning of microinjections into basal ganglia of D1 and D2 dopamine receptors agonists and the cannabinoid CB1 antagonist SR141716A in a rat Parkinson\u2019s model","volume":"16","author":"El Banoua","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.lfs.2023.121838_bb0515","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.brainres.2005.12.014","article-title":"Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson\u2019s disease","volume":"1073-1074","author":"Gonz\u00e1lez","year":"2006","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.lfs.2023.121838_bb0520","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bbr.2009.04.035","article-title":"The CB1 antagonist rimonabant is adjunctively therapeutic as well as monotherapeutic in an animal model of Parkinson\u2019s disease","volume":"203","author":"Kelsey","year":"2009","journal-title":"Behav. Brain Res."},{"issue":"7","key":"10.1016\/j.lfs.2023.121838_bb0525","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1476-5381.2011.01278.x","article-title":"Symptom-relieving and neuroprotective effects of the phytocannabinoid \u03949-THCV in animal models of Parkinson\u2019s disease","volume":"163","author":"Garc\u00eda","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0530","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s002130100728","article-title":"Cannabinoid receptor agonist and antagonist effects on motor function in normal and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-treated non-human primates","volume":"156","author":"Meschler","year":"2001","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1016\/j.lfs.2023.121838_bb0535","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.bjp.0707337","article-title":"Cannabidiol in vivo blunts \u03b2-amyloid induced neuroinflammation by suppressing IL-1\u03b2 and iNOS expression","volume":"151","author":"Esposito","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"15","key":"10.1016\/j.lfs.2023.121838_bb0540","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1007\/s00213-014-3478-5","article-title":"Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe\/PS1\u2206E9 mice","volume":"231","author":"Cheng","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.lfs.2023.121838_bb0545","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3233\/JAD-140921","article-title":"Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer\u2019s disease transgenic mice","volume":"42","author":"Cheng","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.lfs.2023.121838_bb0550","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3233\/JAD-141014","article-title":"Cannabis-based medicine reduces multiple pathological processes in A\u03b2PP\/PS1 mice","volume":"43","author":"Aso","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.lfs.2023.121838_bb0555","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/00001756-200305060-00007","article-title":"Effects of cannabinoids in the rat model of Huntington\u2019s disease generated by an intrastriatal injection of malonate","volume":"14","author":"Lastres-Becker","year":"2003","journal-title":"Neuroreport"},{"issue":"15","key":"10.1016\/j.lfs.2023.121838_bb0560","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1097\/00001756-200410250-00015","article-title":"Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo","volume":"15","author":"Lastres-Becker","year":"2004","journal-title":"Neuroreport"},{"issue":"4","key":"10.1016\/j.lfs.2023.121838_bb0565","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1460-9568.2007.05717.x","article-title":"Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors","volume":"26","author":"Sagredo","year":"2007","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.lfs.2023.121838_bb0570","first-page":"261","article-title":"Neuroprotective effect of WIN55,212-2 against 3-nitropropionic acid-induced toxicity in the rat brain: involvement of CB1 and NMDA receptors","volume":"9","author":"Maya-L\u00f3pez","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.lfs.2023.121838_bb0575","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-3-662-46450-2_7","article-title":"The role of the endocannabinoid system in pain","volume":"227","author":"Woodhams","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2023.121838_bb0580","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234176","article-title":"Evaluation of the preclinical analgesic efficacy of naturally derived, orally administered oil forms of \u03949-tetrahydrocannabinol (THC), cannabidiol (CBD), and their 1:1 combination","volume":"15","author":"Linher-Melville","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2023.121838_bb0585","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.2147\/JPR.S258433","article-title":"CBD effects on TRPV1 signaling pathways in cultured DRG neurons","volume":"13","author":"Anand","year":"2020","journal-title":"J. Pain Res."},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5498\/wjp.v6.i1.1","article-title":"Post-traumatic stress disorder risk and brain-derived neurotrophic factor Val66Met","volume":"6","author":"Zhang","year":"2016","journal-title":"World J. Psychiatry"},{"key":"10.1016\/j.lfs.2023.121838_bb0595","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pnpbp.2018.01.026","article-title":"Cannabinoids prevent depressive-like symptoms and alterations in BDNF expression in a rat model of PTSD","volume":"84","author":"Burstein","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.lfs.2023.121838_bb0600","doi-asserted-by":"crossref","first-page":"493","DOI":"10.29252\/nirp.bcn.8.6.493","article-title":"Effect of WIN55-212-2 and consequences of extinction training on conditioned fear memory in PTSD male rats","volume":"8","author":"Ghasemi","year":"2017","journal-title":"BCN"},{"issue":"5","key":"10.1016\/j.lfs.2023.121838_bb0605","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.euroneuro.2018.02.004","article-title":"Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD","volume":"28","author":"Fidelman","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2023.121838_bb0610","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.euroneuro.2015.02.001","article-title":"\u03949-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption","volume":"25","author":"Stern","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"58","key":"10.1016\/j.lfs.2023.121838_bb0615","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/jncimonographs\/lgab008","article-title":"Cannabinoid cancer biology and prevention","volume":"2021","author":"McAllister","year":"2021","journal-title":"J. Natl Cancer Inst. Monogr."},{"key":"10.1016\/j.lfs.2023.121838_bb0620","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.brainres.2006.12.060","article-title":"Distinctive pattern of cannabinoid receptor type II (CB2) expression in adult and pediatric brain tumors","volume":"1137","author":"Ellert-Miklaszewska","year":"2007","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.lfs.2023.121838_bb0625","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1124\/jpet.103.061002","article-title":"Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines","volume":"308","author":"Massi","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0630","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1158\/1535-7163.MCT-09-0407","article-title":"Cannabidiol enhances the inhibitory effects of \u03949-tetrahydrocannabinol on human glioblastoma cell proliferation and survival","volume":"9","author":"Marcu","year":"2010","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.lfs.2023.121838_bb0635","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1124\/jpet.106.105247","article-title":"Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma","volume":"318","author":"Ligresti","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"11","key":"10.1016\/j.lfs.2023.121838_bb0640","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1158\/1535-7163.MCT-09-0448","article-title":"Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer","volume":"8","author":"Qamri","year":"2009","journal-title":"Mol. Cancer Ther."},{"issue":"17\u201318","key":"10.1016\/j.lfs.2023.121838_bb0645","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1101\/gad.315739.118","article-title":"Genetics and biology of prostate cancer","volume":"32","author":"Wang","year":"2018","journal-title":"Genes Dev."},{"issue":"17","key":"10.1016\/j.lfs.2023.121838_bb0650","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.3390\/ijms21176265","article-title":"Cannabinoids and prostate cancer: a systematic review of animal studies","volume":"21","author":"Singh","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2023.121838_bb0655","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/pros.23720","article-title":"Cannabinoid WIN 55,212-2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid-receptor 2 dependent manner","volume":"79","author":"Roberto","year":"2019","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/j.lfs.2023.121838_bb0660","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/pcan.2016.19","article-title":"The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells","volume":"19","author":"Morell","year":"2016","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"6","key":"10.1016\/j.lfs.2023.121838_bb0665","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/sj.bjc.6605245","article-title":"Increased expression of class III \u03b2-tubulin in castration-resistant human prostate cancer","volume":"101","author":"Terry","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2023.121838_bb0670","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejmech.2013.09.043","article-title":"Synthetic cannabinoid quinones: preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity","volume":"70","author":"Morales","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0675","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1476-5381.2012.02027.x","article-title":"Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms","volume":"168","author":"De Petrocellis","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2023.121838_bb0680","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1096\/fj.11-198184","article-title":"Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1","volume":"26","author":"Ramer","year":"2012","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.lfs.2023.121838_bb0685","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0893-133X(00)00197-4","article-title":"\u03949-Tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB1 receptor antagonist\/inverse agonist SR 141716A","volume":"24","author":"Darmani","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0690","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-2999(02)02815-7","article-title":"Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation","volume":"459","author":"Darmani","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2023.121838_bb0695","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0091-3057(01)00531-7","article-title":"Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB(1) receptors in the least shrew","volume":"69","author":"Darmani","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.lfs.2023.121838_bb0700","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s00213-003-1571-2","article-title":"Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew)","volume":"171","author":"Parker","year":"2004","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.lfs.2023.121838_bb0705","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00213-003-1739-9","article-title":"A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew)","volume":"174","author":"Kwiatkowska","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.lfs.2023.121838_bb0715","series-title":"What is Tourette Syndrome?","author":"prevention","year":"2023"},{"issue":"4","key":"10.1016\/j.lfs.2023.121838_bb0725","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1176\/appi.neuropsych.19080178","article-title":"A phase-2 pilot study of a therapeutic combination of \u0394(9)-tetrahydracannabinol and palmitoylethanolamide for adults with Tourette\u2019s syndrome","volume":"33","author":"Bloch","year":"2021","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.lfs.2023.121838_bb0730","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.drugpo.2019.08.009","article-title":"Taking opioids in times of crisis: institutional oversight, chronic pain and suffering in an integrated healthcare delivery system in the U.S","volume":"74","author":"Gru\u00df","year":"2019","journal-title":"Int. J. Drug Policy"},{"issue":"2","key":"10.1016\/j.lfs.2023.121838_bb0735","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.lfs.2023.121838_bb0745","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.10874","article-title":"Effect of inhaled cannabis for pain in adults with sickle cell disease: a randomized clinical trial","volume":"3","author":"Abrams","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"6","key":"10.1016\/j.lfs.2023.121838_bb0755","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/AOG.0000000000003850","article-title":"Cannabinoids for pain control during medical abortion: a randomized controlled trial","volume":"135","author":"Colwill","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.lfs.2023.121838_bb0760","series-title":"Desk Reference to the Diagnostic Criteria From DSM-5","author":"Association","year":"2014"},{"issue":"21","key":"10.1016\/j.lfs.2023.121838_bb0765","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16214149","article-title":"Cannabis and psychosis through the lens of DSM-5","volume":"16","author":"Pearson","year":"2019","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"7","key":"10.1016\/j.lfs.2023.121838_bb0775","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00213-018-4885-9","article-title":"The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial","volume":"235","author":"Boggs","year":"2018","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.lfs.2023.121838_bb0785","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246990","article-title":"The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: a randomized cross-over clinical trial","volume":"16","author":"Bonn-Miller","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0810","first-page":"17","article-title":"Interaction between Chinese herbal medicines and drugs","volume":"2","author":"Li","year":"2007","journal-title":"Aust. J. Acupunct. Chin. Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0815","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/bcpt.13152","article-title":"Interaction between warfarin and cannabis","volume":"124","author":"Damkier","year":"2019","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"9","key":"10.1016\/j.lfs.2023.121838_bb0820","doi-asserted-by":"crossref","first-page":"E206","DOI":"10.1503\/cmaj.191097","article-title":"Drug interactions with cannabinoids","volume":"192","author":"Antoniou","year":"2020","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.lfs.2023.121838_bb0825","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8070989","article-title":"Potential adverse drug events and drug\u2013drug interactions with medical and consumer cannabidiol (CBD) use","volume":"8","author":"Brown","year":"2019","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0830","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/2193-1801-2-236","article-title":"A phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of rifampicin, ketoconazole, and omeprazole on the pharmacokinetics of THC\/CBD oromucosal spray in healthy volunteers","volume":"2","author":"Stott","year":"2013","journal-title":"Springerplus"},{"issue":"3","key":"10.1016\/j.lfs.2023.121838_bb0835","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jamapsychiatry.2013.3947","article-title":"Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial","volume":"71","author":"Allsop","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.lfs.2023.121838_bb0840","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pharmthera.2019.05.001","article-title":"A marijuana-drug interaction primer: precipitants, pharmacology, and pharmacokinetics","volume":"201","author":"Cox","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.lfs.2023.121838_bb0845","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/epi.13060","article-title":"Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy","volume":"56","author":"Geffrey","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.lfs.2023.121838_bb0850","first-page":"13","article-title":"Contemplating cannabis? The complex relationship between cannabinoids and hepatic metabolism resulting in the potential for drug-drug interactions","author":"Smith","year":"2023","journal-title":"Front. Psychiatry"},{"issue":"5","key":"10.1016\/j.lfs.2023.121838_bb0855","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/cpt.1381","article-title":"Positive and negative effects of cannabis and cannabinoids on health","volume":"105","author":"Cohen","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.lfs.2023.121838_bb0860","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13311-015-0380-8","article-title":"Safety and toxicology of cannabinoids","volume":"12","author":"Sachs","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0865","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1183\/09031936.00065009","article-title":"Effects of cannabis on lung function: a population-based cohort study","volume":"35","author":"Hancox","year":"2010","journal-title":"Eur. Respir. J."},{"issue":"S1","key":"10.1016\/j.lfs.2023.121838_bb0870","doi-asserted-by":"crossref","first-page":"71s","DOI":"10.1002\/j.1552-4604.2002.tb06006.x","article-title":"Respiratory and immunologic consequences of marijuana smoking","volume":"42","author":"Tashkin","year":"2002","journal-title":"J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2023.121838_bb0875","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13020117","article-title":"Cannabis: a toxin-producing plant with potential therapeutic uses","volume":"13","author":"Breijyeh","year":"2021","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.lfs.2023.121838_bb0880","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.forsciint.2014.02.001","article-title":"Sudden unexpected death under acute influence of cannabis","volume":"237","author":"Hartung","year":"2014","journal-title":"Forensic Sci. Int."},{"issue":"16","key":"10.1016\/j.lfs.2023.121838_bb0885","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/S0024-3205(02)02474-8","article-title":"Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart","volume":"72","author":"Bouchard","year":"2003","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0890","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.amjcard.2013.09.042","article-title":"Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know","volume":"113","author":"Thomas","year":"2014","journal-title":"Am. J. Cardiol."},{"issue":"8","key":"10.1016\/j.lfs.2023.121838_bb0895","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.imbio.2009.12.005","article-title":"Cannabinoids and the immune system: an overview","volume":"215","author":"Tanasescu","year":"2010","journal-title":"Immunobiology"},{"issue":"2","key":"10.1016\/j.lfs.2023.121838_bb0900","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00003081-199306000-00011","article-title":"Prenatal exposure to tobacco and marijuana: effects during pregnancy, infancy, and early childhood","volume":"36","author":"Fried","year":"1993","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.lfs.2023.121838_bb0905","series-title":"Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential","author":"Russo","year":"2002"},{"issue":"4","key":"10.1016\/j.lfs.2023.121838_bb0910","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/JU.0000000000000248","article-title":"Cannabis and male fertility: a systematic review","volume":"202","author":"Payne","year":"2019","journal-title":"J. Urol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121838_bb0915","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.fertnstert.2009.01.153","article-title":"The CB<sub>2<\/sub> cannabinoid receptor regulates human sperm cell motility","volume":"93","author":"Agirregoitia","year":"2010","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.lfs.2023.121838_bb0920","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0278-5846(85)90085-5","article-title":"Health consequences of acute and chronic marihuana use","volume":"9","author":"Maykut","year":"1985","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.lfs.2023.121838_bb0925","series-title":"Marihuana and Medicine","first-page":"367","author":"Hembree","year":"1999"},{"issue":"8","key":"10.1016\/j.lfs.2023.121838_bb0930","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis","volume":"29","author":"D\u2019Souza","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.lfs.2023.121838_bb0935","series-title":"Understanding Marijuana: A New Look at the Scientific Evidence","author":"Earleywine","year":"2002"},{"issue":"4","key":"10.1016\/j.lfs.2023.121838_bb0940","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/bja\/83.4.637","article-title":"Adverse effects of cannabis and cannabinoids","volume":"83","author":"Ashton","year":"1999","journal-title":"Br. J. Anaesth."},{"issue":"1","key":"10.1016\/j.lfs.2023.121838_bb0945","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1017\/S0033291702006402","article-title":"Cannabis dependence and psychotic symptoms in young people","volume":"33","author":"Fergusson","year":"2003","journal-title":"Psychol. Med."},{"key":"10.1016\/j.lfs.2023.121838_bb0950","series-title":"FDA and Cannabis: Research and Drug Approval Process","author":"FDA","year":"2022"},{"key":"10.1016\/j.lfs.2023.121838_bb0955","series-title":"EMEA-000181-PIP01-08-M03","author":"EMA","year":"2022"},{"key":"10.1016\/j.lfs.2023.121838_bb0960","series-title":"Refusal of Orphan Designation for the Treatment of Amyotropic Lateral Sclerosis","author":"EMA","year":"2022"},{"key":"10.1016\/j.lfs.2023.121838_bb0965","author":"UK"},{"key":"10.1016\/j.lfs.2023.121838_bb0970","author":"UK"},{"key":"10.1016\/j.lfs.2023.121838_bb0975","author":"FDA"},{"key":"10.1016\/j.lfs.2023.121838_bb0980","author":"FDA"},{"key":"10.1016\/j.lfs.2023.121838_bb0985","author":"FDA"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523004733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523004733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T19:40:50Z","timestamp":1736365250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523004733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":187,"alternative-id":["S0024320523004733"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121838","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121838","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"121838"}}